GLYCOPYRROLATE INJECTION — Class III drug recall D-0870-2023
Terminated recall by HF Acquisition Co LLC, reported 2023-06-14, distributed in AZ, CA, TX. Labeling: Label Mix-up
| Recall number | D-0870-2023 |
|---|---|
| Product type | Drug |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | HF Acquisition Co LLC, Mukilteo, WA, United States |
| Recall initiated | 2023-06-06 |
| Classified | 2023-06-08 |
| Reported by FDA | 2023-06-14 |
| Terminated | 2024-02-27 |
| Distributed | AZ, CA, TX |
| Reason classes | labeling |
| NDC | 51662-1487, 51662-1487-01, 51662-1487-02, 51662-1487-03 |
| Lot numbers | 2205095.1 |
| Expiration dates | 2024-07-31 |
Product
GLYCOPYRROLATE INJECTION, USP 0.2MG/ML, 1mL VIAL, manufactured by HF Acquisition Co. LLC, Mukilteo, WA 98275, NDC 51662-1487-3
Reason for recall
Labeling: Label Mix-up
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0870-2023. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.